News Detail
New Delhi, 3 Apr 2024 (KNN) India's efforts to reduce its dependence on China for crucial drugs have received a significant boost, with two domestic drug makers poised to commence production of the key antibiotic raw materials, penicillin G and clavulanic acid, this year......
View Details
Source : KNN
New Delhi
Apr 2 (KNN) India's efforts to reduce its dependence on China for crucial drugs have received a significant boost
with two domestic drug makers poised to commence production of the key antibiotic raw materials
penicillin G and clavulanic acid
this year. This development is made possible by the government's ambitious Production-Linked Incentive (PLI) scheme
designed to bolster domestic manufacturing of essential pharmaceutical ingredients
reported ET. According to industry executives
the stage is set for Hyderabad-based Aurobindo Pharma and Mumbai-headquartered Kinvan to begin production of the key starting materials (KSMs) penicillin G and clavulanic acid
respectively. The companies are expected to roll out their first batches in the coming months
marking a significant milestone in India's pursuit of self-reliance in the pharmaceutical sector. Penicillin G
a crucial input for several antibiotics
and clavulanic acid
used in manufacturing the widely popular anti
Related News
- Fake degrees seized from pvt institute in Hisar (13-12-2024)
- Health ministry assign testing labs for surgical and medical examination gloves (13-12-2024)
- DCGI asks States to approve all applications for medicines and medical devices for rare diseases within three months (13-12-2024)
- Karnataka to restructure drugs control dept, strengthen procedures (13-12-2024)
- US FDA identifies cases of liver injury after treatment with Intercept's Ocaliva (obeticholic acid) (13-12-2024)
- Fake platelets sold for 15 thousand rupees in Prayagraj, CMO ordered an inquiry (12-12-2024)
- Cardiac drug sales signal increase in heart ailments (12-12-2024)
- Banned cough syrup worth Rs 15 lakh seized, driver arrested (12-12-2024)
- Sales in the respiratory market reached Rs 1,638 crore in November 2024 (12-12-2024)
- Kenya Govt Cautions Kenyans after Unregistered Cancer Drug Hits Market (12-12-2024)